Upload
thuyet
View
22
Download
0
Tags:
Embed Size (px)
DESCRIPTION
A CPMC Regional CME Event. Thyroid Treatment and Vitamin D Update. - An Integrated Approach. Saturday October 27, 2012. Hypothyroidism. Diana M. Antoniucci, MD, MAS Sutter Pacific Medical Foundation Division of Endocrinology, Diabetes and Osteoporosis Assistant Clinical Professor Medicine - PowerPoint PPT Presentation
Citation preview
THYROID TREATMENT AND VITAMIN D UPDATEA CPMC Regional CME Event
- An Integrated Approach
Saturday October 27, 2012
HYPOTHYROIDISM
Diana M. Antoniucci, MD, MASSutter Pacific Medical Foundation
Division of Endocrinology, Diabetes and OsteoporosisAssistant Clinical Professor Medicine
University of California, San Francisco
IN YOUR OFFICE…
• 56 yo man presents complaining of fatigue and constipation
• His PMHx is significant for coronary artery disease
• What is the best screening test for thyroid disease?
HYPOTHYROIDISM
• 2% of adult women • 0.1-0.2% of adult men
Fatigue
Forgetfulness/Slower ThinkingMoodiness/ Irritability
DepressionInability to ConcentrateThinning Hair/Hair Loss
Loss of Body Hair
Dry, Patchy Skin
Weight GainCold Intolerance
Elevated CholesterolFamily History of Thyroid Disease
or Diabetes 1
Muscle Weakness/Cramps
Constipation
Infertility
Menstrual Irregularities/Heavy Period
Slower HR and low voltage ECGDifficulty Swallowing
Persistent Dry or Sore Throat
Hoarseness/Deepening of Voice
Small or Enlarged Thyroid (Goiter)
Peri-orbital Edema
CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
• Hashimoto’s, or autoimmune thyroiditis – most common
• Drugs: amiodarone, lithium, interferon, iodide
• Iatrogenic: post surgical, post RAI rx or post XRT for neck cancer
• Rare causes: iodine deficiency, central hypothyroidism, peripheral resistance to thyroid hormone.
THYROID TESTS• Thyroid Function Tests (TFTs):
- TSH – good to screen initially- Free T4 – needed to follow patients and to rule out
central thyroid disease- Total or Free T3 – to r/o or r/i T3 thyrotoxicosis only- Thyroglobulin – thyroid cancer or presumed
subacute thyroiditis• Thyroid antibodies
- TPO and Tg Ab’s: sensitive for autoimmune thyroid dz, esp. Hashimoto’s
- TSH rcptr stimulating immunoglobulins (TSI): specific for Graves’ disease
BACK TO OUR CASE…
• His TSH is elevated at 63 uIU/ml (0.4-4.5)
• What other laboratories/studies should you order?
• How could you make a diagnosis of Hashimoto’s?
RESULTS
• His TPO antibodies and TG antibodies are positive
• No need to check ultrasound in this setting
• Thyroglobulin level also not necessary
• Should you treat?• If so with what?
HYPOTHYROIDISM THERAPY
• Standard: synthetic thyroxine (T4)- Little intrinsic activity- Converted to T3 in peripheral tissues- Most physiologic replacement
• Controversy of generics vs brand bioequivalence- 1997 study Synthroid, Levoxyl and 2 generics1
- Used FDA recommended methodology to determine bioequivalence• All 4 preparations were bioequivalent
1Dong BJ et al. JAMA 1997; 277:1205
HYPOTHYROIDISM THERAPY
• Preferable to stay with one formulation when possible (generics – request same manufacturer)
• Levoxyl reportedly easier to absorb than Synthroid
• Tirosint – supposed to be unaffected by concomitant food intake
HYPOTHYROIDISM THERAPY
• Estimated weight based replacement dose:- 1.6 mcg/kg/d
• Dose depends on cause of hypothyroidism and stage of disease- Athyroid patients tend to need higher
doses• Starting dose depends on age, co-
morbidities and TSH
HYPOTHYROIDISM THERAPY
• In young healthy patients, can start full expected dose (1.6 mcg/kg/d)
• Older patients start at 25-50 mcg/d• Goal of therapy
- Symptom amelioration- TSH 1-2 uIU/ml
• Adjust no more often than every 6-8 weeks
• Small adjustments are best: - 12 mcg to at most 25 mcg increments in dose
BACK TO YOUR OFFICE
• 56 yo hypothyroid man with hx of CAD• START LOW AND GO SLOW: Start low doses of
LT4 and slowly increase dose, be particularly careful in patients with heart disease
• Start LT4 12.5-25 mcg po qd. Recheck TFTs in 4-6 weeks and increase dose as needed
• Given his CAD, would start very low, increase every 4 weeks until approaching final expected dose
ANOTHER DAY IN YOUR OFFICE…
• 28 yo woman with long standing hypothyroidism
• On stable replacement dose levothyroxine 112 mcg/d for years
• She reports fatigue, constipation and more irregular cycles
• TSH: 9.5 uIU/ml (0.4-4.5)• Talking to her you discover she added
prenatal vitamins to her regimen…
HOW TO TAKE LEVOTHYROXINE
• Ideally:- 1st thing in AM- Empty stomach- No food for 30 min- Delay any calcium containing foods at
least 1 hr.• Move any iron or calcium containing
supplements to dinner time.
IN THE OFFICE
• She moves prenatal vitamin to dinner time
• 6 weeks later, TSH is back down to 1.2 uIU/ml
• 4 months later, repeat TSH is 3.5 uIU/ml
• What happened?• Pregnancy test is now positive!
HYPOTHYROIDISM IN PREGNANCY
• Requirement of levothyroxine increase 25-50% in pregnancy
• It is common for TSH to rise early on• Recommendations are to maintain TSH <2.5
uIU/ml throughout pregnancy• Check TSH, FT4 and TT4 every 4 weeks in
first 16 weeks and adjust as needed• Management of hypothyroidism in pregnancy
is a very appropriate referral to endocrinology
Journal of Clinical Endocrinology & Metabolism, 97: 2543–2565, 2012).
AND ANOTHER PATIENT…
• 34 yo woman with 5 year history hypothyroidism
• TSH has been between 1-2 uIU/ml (0.4-4.5) for a few yrs
• Reports continued fatigue and not feeling same as before hypothyroidism
• Should you treat her with combination T4 and T3?
HYPOTHYROID PT WITH PERSISTENT SYX
• Symptoms reported:- Fatigue- Diminished concentration and working memory- Poorer psychological well being
• Start with evaluation by PCP:- H&P- Labs: CMP, CBC, ESR, celiac dz testing, sleep apnea
screening or testing• Then Endo evaluation:
- 25OHD- Adrenal evaluation
• Consider possibility of depression
TREATMENT WITH COMBINATION THERAPY
• Multiple randomized trials• Systematic review of 11 randomized trials
- One trial (n=35): beneficial effects on mood, quality of life and psychometric performance of T4-T3 combo vs T4 alone
- Remainder failed to show benefit• Subanalysis in one study1 homozygous
polymorphisms in a deiodinase (in 16% people)- Worse baseline neuro-cognitive scores- Significant improvement with combo T4/T3 rx
1Panicker V et al J Clin Endocrinol Metab 2009; 94: 1623
TREATMENT WITH COMBINATION THERAPY
• Not necessary• Up to 16% hypothyroid patients may
benefit• No genetic test available now• Trial in still symptomatic patients is
reasonable- T4:T3 ratio of 10:1 to 14:1- Typically 2.5-5 mcg liothyronine qd to bid
added to T4- Goals of therapy same
T3 CONTAINING PREPARATIONS
• Include desiccated thyroid (Armour), T4-T3 preparations (Thyrolar, Naturethroid)
• Wide fluctuations in serum T3 concentrations• Often unavailable due to manufacturing issues• T4/T3 Ratio is not physiological• No clear benefit and more difficult to dose and
adjust • Consider referral for convertion to T4 or T4+T3• Avoid in pregnancy
PEARLS
• TSH best screening test• No need to order Tg or ultrasound in patients with
hypothyroidism• Always review how patients are taking LT4 pills• Aim for TSH 1-2• If still symptomatic, consider T3 addition• Sensitivity to TSH changes and how much TSH changes in
response to dose changes are somewhat variable• Refer if:
- Pregnancy- Worried about co-morbidities- TSH is not responding as expected- Patients still fatigued even at goal TSH and other causes of fatigue ruled
out